Cargando…
Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodies
The development and use of combination immunotherapy-based anticancer regimens is at an early but clearly exciting stage. We now demonstrate that the antibody-based co-targeting of multiple immunostimulatory and/or inhibitory pathways can be used safely and effectively in combination with single dos...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525626/ https://www.ncbi.nlm.nih.gov/pubmed/23264917 http://dx.doi.org/10.4161/onci.21652 |